SIT as a promising and exciting approach to control dengue, chikungunya and Zika
The Sterile Insect Technique (SIT) successfully used to target insect pests that attack crops and livestock will now be tested as part of health sector to fight human diseases such as dengue, chikungunya and zika.
The SIT involves rearing huge quantities of sterilized male mosquitoes in dedicated facilities, and then releasing them to mate with females in the wild. As no offspring is produced, the insect population reduces over time... read more
De-humanizing working conditions for sanitation workers need a push for change
According to a recent report, millions of sanitation workers are forced to work in conditions that endanger their health and lives, and violate their dignity and human rights.
This report on the plight of sanitation workers in the developing nations is jointly authored by the International Labour Organization,... read more
FDA's approved Fetroja (cefiderocol) serves as additional therapeutic agent for cUTIs
Fetroja (cefiderocol), an antibacterial drug has been approved by the United States Food and Drug Administration (US FDA) for treatment of patients aged 18 years with complicated urinary tract infections (cUTIs), including kidney infections caused by susceptible Gram-negative microorganisms, who have limited or no alternative treatment options.... read more
PERSEVERE, a new biomarker-based tool to stratify pediatric patients at risk for sepsis
The development of the Pediatric Sepsis Biomarker Risk Model (PERSEVERE) assay may help in predicting septic shock outcomes and selecting early optimal treatment more precisely in kids.
This test has been developed by Hector R. Wong, MD, director of critical care medicine at Cincinnati Children's Hospital Medical Center in Ohio, and colleagues over more than 10 years.... read more
Phase III trial finds a modified vaccine against smallpox non-inferior to the established vaccine
The trial performed in healthy US soldiers revealed that administration of modified vaccinia Ankara, or MVA, had immune responses comparable to established replicating-vaccinia, ACAM2000.
The authors of this study stated that "A single MVA vaccination induced neutralizing antibody titers that were similar to those with ACAM2000 at day 14,.. read more
Electrocardiogram sensor in Apple watch series 4 and 5 is yet to convince cardiologists
The Apple Heart Study assessed the use of Apple Watch in detecting atrial fibrillation, a condition accompanied by high risk of stroke.
The findings published in the New England Journal of Medicine indicates this type of passive monitoring to be effective, however, not everyone in the medical community,... read more